178 related articles for article (PubMed ID: 8332282)
41. Electromagnetic fields in the treatment of postmenopausal osteoporosis: an experimental study conducted by densitometric, dry ash weight and metabolic analysis of bone tissue.
Bilotta TW; Zati A; Gnudi S; Figus E; Giardino R; Fini M; Pratelli L; Mongiorgi R
Chir Organi Mov; 1994; 79(3):309-13. PubMed ID: 7842842
[TBL] [Abstract][Full Text] [Related]
42. Metabolic and hormonal effects of 25-mg and 50-mg 17 beta-estradiol implants in surgically menopausal women.
Notelovitz M; Johnston M; Smith S; Kitchens C
Obstet Gynecol; 1987 Nov; 70(5):749-54. PubMed ID: 3658285
[TBL] [Abstract][Full Text] [Related]
43. [Therapeutic protocols compared in the treatment of postmenopausal osteoporotic disease].
Nardo F; Scrofani V; Costa G; Bellanca S; Petrovec MM; Clemenza F; Licciardello S
Minerva Ginecol; 1994 Jun; 46(6):305-15. PubMed ID: 7936382
[TBL] [Abstract][Full Text] [Related]
44. Relationship between local and total bone mineral content after gastric surgery.
Nilas L; Gotfredsen A; Christiansen C
Scand J Gastroenterol; 1984 Jul; 19(5):591-5. PubMed ID: 6474080
[TBL] [Abstract][Full Text] [Related]
45. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
[TBL] [Abstract][Full Text] [Related]
46. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.
Nielsen NM; von der Recke P; Hansen MA; Overgaard K; Christiansen C
Calcif Tissue Int; 1994 Jul; 55(1):8-11. PubMed ID: 7922794
[TBL] [Abstract][Full Text] [Related]
47. Smoking, the menopause and biochemical parameters of bone loss and bone turnover.
Goulding A
N Z Med J; 1982 Apr; 95(705):218-20. PubMed ID: 6953358
[TBL] [Abstract][Full Text] [Related]
48. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
Mazzuoli GF; Passeri M; Gennari C; Minisola S; Antonelli R; Valtorta C; Palummeri E; Cervellin GF; Gonnelli S; Francini G
Calcif Tissue Int; 1986 Jan; 38(1):3-8. PubMed ID: 3079649
[TBL] [Abstract][Full Text] [Related]
49. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
Overgaard K; Hansen MA; Dirksen KL; Christiansen C
Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
[TBL] [Abstract][Full Text] [Related]
50. [Osteoporosis after oophorectomy].
Minaguchi H; Gorai I
Nihon Rinsho; 1990 Dec; 48(12):2893-7. PubMed ID: 2086851
[No Abstract] [Full Text] [Related]
51. [Certain changes in mineral metabolism of patients with osteoarthrosis and osteoporosis under the influence of combined treatment].
Kamalova NA
Vopr Kurortol Fizioter Lech Fiz Kult; 2011; (2):16-8. PubMed ID: 21584954
[TBL] [Abstract][Full Text] [Related]
52. [Mineral bone density and mineral exchange status in patients with chronic generalized periodontitis].
Dmitrieva LA; Mkrtumian AM; Atrushkevich VG
Stomatologiia (Mosk); 2009; 88(6):24-8. PubMed ID: 20081775
[TBL] [Abstract][Full Text] [Related]
53. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
Polatti F; Perotti F; Angelini GP; Vassellatti D; Rapisardi I
Maturitas; 1993 Dec; 18(1):73-6. PubMed ID: 8107619
[TBL] [Abstract][Full Text] [Related]
54. Physical activity and calcium modalities for bone mineral increase in aged women.
Smith EL; Reddan W; Smith PE
Med Sci Sports Exerc; 1981; 13(1):60-4. PubMed ID: 7219137
[TBL] [Abstract][Full Text] [Related]
55. [Prevention of post-ovariectomy osteoporosis in the rat. Comparative study of synthetic salmon calcitonin and eel calcitonin aminosuberic analogue].
Gnudi S; Zati A; Giardino R; Fini M; Pratelli L; Orlandi M; Figus E
Minerva Endocrinol; 1993 Sep; 18(3):123-7. PubMed ID: 8183179
[TBL] [Abstract][Full Text] [Related]
56. [Effect of early menopause by ovariectomy on bone loss].
Pouillès JM; Trémollières F; Ribot C
Presse Med; 1994 Apr; 23(14):653-6. PubMed ID: 8072962
[TBL] [Abstract][Full Text] [Related]
57. Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis.
Robin JC; Ambrus JL
Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):491-8. PubMed ID: 7079575
[TBL] [Abstract][Full Text] [Related]
58. [Treatment of primary osteoporosis with calcium and salmon calcitonin].
Ringe JD
Dtsch Med Wochenschr; 1990 Aug; 115(31-32):1176-82. PubMed ID: 2199180
[TBL] [Abstract][Full Text] [Related]
59. Use of nasally administered salmon calcitonin in preventing bone loss.
Christiansen C
Calcif Tissue Int; 1991; 49 Suppl 2():S14-5. PubMed ID: 1933614
[TBL] [Abstract][Full Text] [Related]
60. Effects of nasal administration of calcitonin in oophorectomized women: 2-year controlled double-blind study.
Grigoriou O; Papoulias I; Vitoratos N; Papadias C; Konidaris S; Antoniou G; Chryssikopoulos A
Maturitas; 1997 Dec; 28(2):147-51. PubMed ID: 9522322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
